{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:26:30Z","timestamp":1791206790108,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,10,8]],"date-time":"2014-10-08T00:00:00Z","timestamp":1412726400000},"content-version":"vor","delay-in-days":372,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Structure"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.str.2013.07.017","type":"journal-article","created":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T16:27:16Z","timestamp":1377188836000},"page":"1889-1896","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Structural Mimicry of A-Loop Tyrosine Phosphorylation by a Pathogenic FGF Receptor 3 Mutation"],"prefix":"10.1016","volume":"21","author":[{"given":"Zhifeng","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaibin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Blais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas\u00a0A.","family":"Neubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moosa","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.str.2013.07.017_bib1","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1107\/S0907444902016657","article-title":"PHENIX: building new software for automated crystallographic structure determination","volume":"58","author":"Adams","year":"2002","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.str.2013.07.017_bib2","doi-asserted-by":"crossref","first-page":"6909","DOI":"10.1038\/sj.onc.1206798","article-title":"The phosphotyrosine phosphatase SHP2 is a critical mediator of transformation induced by the oncogenic fibroblast growth factor receptor 3","volume":"22","author":"Agazie","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.str.2013.07.017_bib3","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.cell.2009.05.028","article-title":"The selectivity of receptor tyrosine kinase signaling is controlled by a secondary SH2 domain binding site","volume":"138","author":"Bae","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.str.2013.07.017_bib4","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1073\/pnas.0914157107","article-title":"Asymmetric receptor contact is required for tyrosine autophosphorylation of fibroblast growth factor receptor in living cells","volume":"107","author":"Bae","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.str.2013.07.017_bib5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrd2792","article-title":"The FGF family: biology, pathophysiology and therapy","volume":"8","author":"Beenken","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.str.2013.07.017_bib6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ng0795-357","article-title":"A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia","volume":"10","author":"Bellus","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.str.2013.07.017_bib7","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1086\/316892","article-title":"Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype","volume":"67","author":"Bellus","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.str.2013.07.017_bib8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/12615","article-title":"Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas","volume":"23","author":"Cappellen","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.str.2013.07.017_bib9","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.molcel.2007.06.028","article-title":"A molecular brake in the kinase hinge region regulates the activity of receptor tyrosine kinases","volume":"27","author":"Chen","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.str.2013.07.017_bib10","doi-asserted-by":"crossref","first-page":"19660","DOI":"10.1073\/pnas.0807752105","article-title":"A crystallographic snapshot of tyrosine trans-phosphorylation in action","volume":"105","author":"Chen","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.str.2013.07.017_bib11","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.celrep.2013.06.025","article-title":"Cracking the molecular origin of\u00a0intrinsic tyrosine kinase activity through analysis of pathogenic gain-of-function mutations","volume":"4","author":"Chen","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.str.2013.07.017_bib12","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/ng0797-260","article-title":"Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3","volume":"16","author":"Chesi","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.str.2013.07.017_bib13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature04105","article-title":"Intrinsic dynamics of an enzyme underlies catalysis","volume":"438","author":"Eisenmesser","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.str.2013.07.017_bib14","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.str.2013.07.017_bib15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/humu.21636","article-title":"Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias","volume":"33","author":"Foldynova-Trantirkova","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.str.2013.07.017_bib16","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.molcel.2006.01.022","article-title":"Autophosphorylation of FGFR1 kinase is mediated by a sequential and precisely ordered reaction","volume":"21","author":"Furdui","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.str.2013.07.017_bib17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nrm3528","article-title":"Exploring mechanisms of FGF signalling through the lens of structural biology","volume":"14","author":"Goetz","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.str.2013.07.017_bib18","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/ng.470","article-title":"Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors","volume":"41","author":"Goriely","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.str.2013.07.017_bib19","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.cellsig.2008.04.001","article-title":"Sprouty 2 disturbs FGFR3 degradation in thanatophoric dysplasia type II: a severe form of human achondroplasia","volume":"20","author":"Guo","year":"2008","journal-title":"Cell. Signal."},{"key":"10.1016\/j.str.2013.07.017_bib20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1146\/annurev.biochem.69.1.373","article-title":"Protein tyrosine kinase structure and function","volume":"69","author":"Hubbard","year":"2000","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.str.2013.07.017_bib21","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1107\/S0108767390010224","article-title":"Improved methods for building protein models in electron density maps and the location of errors in these models","volume":"47","author":"Jones","year":"1991","journal-title":"Acta Crystallogr. A"},{"key":"10.1016\/j.str.2013.07.017_bib22","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1086\/338758","article-title":"Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis","volume":"70","author":"Kan","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.str.2013.07.017_bib23","doi-asserted-by":"crossref","first-page":"17344","DOI":"10.1074\/jbc.M212710200","article-title":"The thanatophoric dysplasia type II mutation hampers complete maturation of fibroblast growth factor receptor 3 (FGFR3), which activates signal transducer and activator of transcription 1 (STAT1) from the endoplasmic reticulum","volume":"278","author":"Lievens","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.str.2013.07.017_bib24","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/hmg\/ddi127","article-title":"Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans","volume":"14","author":"Logi\u00e9","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.str.2013.07.017_bib25","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0092-8674(00)80131-2","article-title":"Structure of the\u00a0FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism","volume":"86","author":"Mohammadi","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.str.2013.07.017_bib26","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/MCB.16.3.977","article-title":"Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction","volume":"16","author":"Mohammadi","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.str.2013.07.017_bib27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/ng0696-233","article-title":"Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia","volume":"13","author":"Naski","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.str.2013.07.017_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1107\/S0108767393007597","article-title":"Amore - an automated package for molecular replacement","volume":"50","author":"Navaza","year":"1994","journal-title":"Acta Crystallogr. A"},{"key":"10.1016\/j.str.2013.07.017_bib29","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/hmg\/ddi161","article-title":"Sustained ERK1\/2 but not STAT1 or 3 activation is required for thanatophoric dysplasia phenotypes in PC12 cells","volume":"14","author":"Nowroozi","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.str.2013.07.017_bib30","series-title":"Methods in Enzymology","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of X-ray diffraction data collected in oscillation mode","author":"Otwinowski","year":"1997"},{"key":"10.1016\/j.str.2013.07.017_bib31","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ng0395-321","article-title":"Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3","volume":"9","author":"Tavormina","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.str.2013.07.017_bib32","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.cbpa.2010.08.007","article-title":"Choreographing an enzyme\u2019s dance","volume":"14","author":"Villali","year":"2010","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.str.2013.07.017_bib33","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1128\/MCB.17.10.5739","article-title":"Enhanced signaling and morphological transformation by a membrane-localized derivative of the fibroblast growth factor receptor 3 kinase domain","volume":"17","author":"Webster","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.str.2013.07.017_bib34","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0168-9525(97)01131-1","article-title":"FGFR activation in skeletal disorders: too much of a good thing","volume":"13","author":"Webster","year":"1997","journal-title":"Trends Genet."},{"key":"10.1016\/j.str.2013.07.017_bib35","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1128\/MCB.16.8.4081","article-title":"Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysplasia type II","volume":"16","author":"Webster","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.str.2013.07.017_bib36","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/(SICI)1096-8628(19980707)78:3<274::AID-AJMG14>3.0.CO;2-C","article-title":"Molecular, radiologic, and histopathologic correlations in thanatophoric dysplasia","volume":"78","author":"Wilcox","year":"1998","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.str.2013.07.017_bib37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cytogfr.2005.03.001","article-title":"Bad bones, absent smell, selfish testes: the pleiotropic consequences of human FGF receptor mutations","volume":"16","author":"Wilkie","year":"2005","journal-title":"Cytokine Growth Factor Rev."}],"container-title":["Structure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969212613002670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969212613002670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T02:30:58Z","timestamp":1760841058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969212613002670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0969212613002670"],"URL":"https:\/\/doi.org\/10.1016\/j.str.2013.07.017","relation":{},"ISSN":["0969-2126"],"issn-type":[{"value":"0969-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural Mimicry of A-Loop Tyrosine Phosphorylation by a Pathogenic FGF Receptor 3 Mutation","name":"articletitle","label":"Article Title"},{"value":"Structure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.str.2013.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}